New Marketplace
Clip
Room for Small, Independent Practices? (02:30)

There is plenty of room for small independent practices, says Harvard health policy expert and internist Michael McWilliams — and too much emphasis on downside risk. “I don’t know what that really gets us. It requires scale and some degree of consolidation,” he says. Evidence shows that the most effective payment model in terms of savings thus far is the Medicare Shared Savings Program, which is essentially devoid of downside risk. “With the right regulations in place, the right models, there is no reason why a smaller practice can’t be in a one-sided contract and make inroads.”

Griffin Myers, Chief Medical Officer for Oak Street Health, somewhat disagrees, pointing to the problem with romanticizing small independent practices. “[When] we say that medicine is so hard and it’s technical and it’s like rocket science, and it requires all this training, but then at the same time, I can do it and I can have a family member be my accountant and still do it — that doesn’t make sense to me,” he says. “It’s very hard to do something really well meaningfully, consistently, if it’s hard, and do it by yourself without a team.” Small practices don’t necessarily have the infrastructure or resources to measure “all of the things that we know matter.”

It depends on what we mean by small, adds McWilliams. The literature suggests that after a dozen or so physicians, practices have plenty of room for scale without hospital integration, as well as the capabilities for measurement and taking on risk.

From the NEJM Catalyst event Navigating Payment Reform for Providers, Payers, and Pharma, held at Harvard Business School, November 2, 2017.

More From New Marketplace
Liljenquist01_pullquote generic drugs

Addressing Generic-Drug Market Failures — The Case for Establishing a Nonprofit Manufacturer

A consortium of hospitals and health plans is establishing a nonprofit generic-drug manufacturer to produce a steady supply of affordable essential drugs and stimulate competition in generic-drug markets.

Shrank02_pullquote IDFS

Effective Consolidation: A Model for Reform Through Payer-Provider Integration

UPMC’s payer-provider partnership integrates real-time data to support improved clinical decision-making and optimizes clinical and financial performance.

Millenson01_pullquote big data analytics SDOH

Big Data on Social Determinants: Improved Health and Unaddressed Privacy Concerns

The use of psychographic data by health systems and health plans could provoke a backlash if not done with patient consent.

Effect of Value-Based Payment Programs on Providers That Serve the Poor

Financial Incentives and Vulnerable Populations — Will Alternative Payment Models Help or Hurt?

Understanding APMs’ potential consequences for vulnerable populations is critical if we wish to maximize benefits and reduce harms.

Example 4-Quadrant Analysis and Price Setting for a Single-Procedure Bundle - Lessons Learned from DRG Implementation

Making Bundled Payments Work: Leveraging the CMS DRG Experience

Given its clout and experience, CMS is uniquely positioned to lead the U.S. health system toward high-value care. Bundled pricing based on real costs, leveraging lessons from DRG implementation, would establish the right types of provider incentives.

Kocher03_pullquote risk-based primary care provider

Opportunities for Risk-Taking Primary Care Providers

Embracing two-sided risk while adopting workflow redesign and reviewing benchmarks is leading to improved clinical and financial outcomes.

The Unrealized Potential of EMRs: Interoperability and the Opportunity for Disruption

NEJM Catalyst hosted clinical and business leaders, along with the originator of “disruptive innovation,” to consider the user frustration, high cost, and lack of interoperability of electronic medical records.

Steven Seltzer Andrew Menard Clayton Christensen Edward Prewitt Electronic Medical Records Roundtable Head Shots

The Unrealized Potential of EMRs: Why They Fall Short and the Unexpected Source of a Solution

NEJM Catalyst hosted clinical and business leaders, along with the originator of “disruptive innovation,” to consider the user frustration, high cost, and lack of interoperability of electronic medical records.

Robert Gavin head shot

Amazon and CVS: Short-Lived Unicorns in Health Care, or Healers of the “Tapeworm”?

Will Amazon–Berkshire Hathaway–JP Morgan and CVS-Aetna change the health care game? To one health care employer purchaser, these announcements feel a lot like Groundhog Day.

Fiona Scott Morton head shot

We Can’t Spend All Our Money on Health Care

We have to think about how much we want to spend on health according to how much it’s worth to us at the margin.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Financial Incentives and Vulnerable Populations —…

Understanding APMs’ potential consequences for vulnerable populations is critical if we wish to maximize benefits…

Addressing Generic-Drug Market Failures — The…

A consortium of hospitals and health plans is establishing a nonprofit generic-drug manufacturer to produce…

Value Based Care

164 Articles

Effective Consolidation: A Model for Reform…

UPMC’s payer-provider partnership integrates real-time data to support improved clinical decision-making and optimizes clinical and…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now